Thereby, it has been suggested that glioma cells expressing mutant IDH1 have a diminished antioxidant capacity and therefore may experience a subsequent loss of cytoprotection under conditions of oxidative stress [36,75,76,77]. The gene discussed is IDH1; the disease is central nervous system cancer.